Treace Medical posts investor presentation for J.P. Morgan Healthcare Conference; reaffirms growth outlook

TREACE MEDICAL CONCEPTS, INC.

Presentation filed as Exhibit 99.1, available on company IR website.
CEO John T. Treace to present at J.P. Morgan Healthcare Conference on Jan 9, 2024.
Presentation states company is 'on solid footing for sustained top-tier growth'.
No specific financial guidance or new product data disclosed in the filed exhibit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.